March 1995: AC meeting

• Should muscle relaxants be considered for OTC use?

• What should the OTC indication be?

• Should there be dose modifications?

• Should use be limited?

• Recommend OTC statement of identity.

Previous slide

Next slide

Back to first slide

View graphic version